192 related articles for article (PubMed ID: 30572916)
21. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis.
Hamdan M; Dunselman G; Li TC; Cheong Y
Hum Reprod Update; 2015; 21(6):809-25. PubMed ID: 26168799
[TBL] [Abstract][Full Text] [Related]
22. [Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle].
Zhang XR; Ding LL; Tang R; Sheng Y; Qin YY; Chen ZJ
Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):180-5. PubMed ID: 27030496
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of In Vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI) Among Patients with Endometriosis After a Shortened Protocol of Long-Term Pituitary Downregulation.
Kong H; Bu Z; Guo Y; Wang F; Shi H; Hu L; Sun Y
Med Sci Monit; 2019 Jun; 25():4377-4383. PubMed ID: 31187785
[TBL] [Abstract][Full Text] [Related]
24. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
[TBL] [Abstract][Full Text] [Related]
26. Adenomyosis has no adverse effects on IVF/ICSI outcomes in women with endometriosis treated with long-term pituitary down-regulation before IVF/ICSI.
Mijatovic V; Florijn E; Halim N; Schats R; Hompes P
Eur J Obstet Gynecol Reprod Biol; 2010 Jul; 151(1):62-5. PubMed ID: 20409633
[TBL] [Abstract][Full Text] [Related]
27. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
28. Predictors of IVF/ICSI success following treatment of endometriosis as the cause of primary infertility.
Bila JS; Vidakovic S; Radjenovic SS; Dokic M; Surlan L; Sparic R
Ginekol Pol; 2018; 89(5):240-248. PubMed ID: 30084475
[TBL] [Abstract][Full Text] [Related]
29. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; van Wely M
Cochrane Database Syst Rev; 2010 Nov; (11):CD008046. PubMed ID: 21069701
[TBL] [Abstract][Full Text] [Related]
30. Ovarian stimulation in in vitro fertilization with or without the "long" gonadotropin-releasing hormone agonist protocol: effect on cycle duration and outcome.
Beloosesky R; Kol S; Lightman A; Itskovitz-Eldor J
Fertil Steril; 2000 Jul; 74(1):166-8. PubMed ID: 10899516
[TBL] [Abstract][Full Text] [Related]
31. GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study.
Ata B; Yakin K; Balaban B; Urman B
Hum Reprod; 2008 Mar; 23(3):668-73. PubMed ID: 18192671
[TBL] [Abstract][Full Text] [Related]
32. Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?
Ren J; Sha A; Han D; Li P; Geng J; Ma C
Fertil Steril; 2014 Jul; 102(1):75-81. PubMed ID: 24746740
[TBL] [Abstract][Full Text] [Related]
33. Long-acting FSH versus daily FSH for women undergoing assisted reproduction.
Pouwer AW; Farquhar C; Kremer JA
Cochrane Database Syst Rev; 2012 Jun; (6):CD009577. PubMed ID: 22696386
[TBL] [Abstract][Full Text] [Related]
34. Hysteroscopic proximal tubal occlusion versus laparoscopic salpingectomy as a treatment for hydrosalpinges prior to IVF or ICSI: an RCT.
Dreyer K; Lier MC; Emanuel MH; Twisk JW; Mol BW; Schats R; Hompes PG; Mijatovic V
Hum Reprod; 2016 Sep; 31(9):2005-16. PubMed ID: 27209341
[TBL] [Abstract][Full Text] [Related]
35. Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis.
Mahmoud Youssef MA; van Wely M; Aboulfoutouh I; El-Khyat W; van der Veen F; Al-Inany H
Fertil Steril; 2012 Apr; 97(4):876-85. PubMed ID: 22277766
[TBL] [Abstract][Full Text] [Related]
36. Association between the number of oocytes retrieved and cumulative live birth rate in women aged 35-40 years undergoing long GnRH agonist IVF/ICSI cycles.
Zhou J; Wang B; Hu Y; Sun H
Arch Gynecol Obstet; 2017 Nov; 296(5):1005-1012. PubMed ID: 28879481
[TBL] [Abstract][Full Text] [Related]
37. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
Kolibianakis EM; Venetis CA; Bosdou JK; Zepiridis L; Chatzimeletiou K; Makedos A; Masouridou S; Triantafillidis S; Mitsoli A; Tarlatzis BC
Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
[TBL] [Abstract][Full Text] [Related]
38. A novel modified ultra-long agonist protocol improves the outcome of high body mass index women with polycystic ovary syndrome undergoing IVF/ICSI.
Tu J; Lin G; Lu C; Gong F
Gynecol Endocrinol; 2014 Mar; 30(3):209-12. PubMed ID: 24351071
[TBL] [Abstract][Full Text] [Related]
39. GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.
Prapas Y; Ravanos K; Petousis S; Panagiotidis Y; Papatheodorou A; Margioula-Siarkou C; Iuliano A; Gullo G; Prapas N
J Assist Reprod Genet; 2017 Nov; 34(11):1537-1545. PubMed ID: 28776117
[TBL] [Abstract][Full Text] [Related]
40. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.
König TE; van der Houwen LE; Overbeek A; Hendriks ML; Beutler-Beemsterboer SN; Kuchenbecker WK; Renckens CN; Bernardus RE; Schats R; Homburg R; Hompes PG; Lambalk CB
Hum Reprod; 2013 Oct; 28(10):2804-12. PubMed ID: 23838159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
